Does OMALIZUMAB Cause Injection site rash? 111 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Injection site rash have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.2% of all adverse event reports for OMALIZUMAB.
111
Reports of Injection site rash with OMALIZUMAB
0.2%
of all OMALIZUMAB reports
0
Deaths
20
Hospitalizations
How Dangerous Is Injection site rash From OMALIZUMAB?
Of the 111 reports, 20 (18.0%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Injection site rash Listed in the Official Label?
Yes, Injection site rash is listed as a known adverse reaction in the official FDA drug label for OMALIZUMAB.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Injection site rash?
ETANERCEPT (3,781)
DUPILUMAB (3,566)
ADALIMUMAB (2,108)
TIRZEPATIDE (1,131)
IXEKIZUMAB (526)
DULAGLUTIDE (501)
EVOLOCUMAB (465)
TERIPARATIDE (426)
SARILUMAB (424)
HYDROXYPROGESTERONE CAPROATE (384)
Which OMALIZUMAB Alternatives Have Lower Injection site rash Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS